Rare hypoaldosteronism

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:181419
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare hypoaldosteronism (Orphanet code 181419) is a group of uncommon endocrine disorders characterized by deficient production or impaired action of aldosterone, the primary mineralocorticoid hormone produced by the adrenal glands. Aldosterone plays a critical role in regulating sodium and potassium balance and maintaining blood pressure through its action on the kidneys. When aldosterone is deficient or its signaling is impaired, patients may develop hyperkalemia (elevated blood potassium levels), hyponatremia (low blood sodium levels), metabolic acidosis, dehydration, and hypotension (low blood pressure). These electrolyte disturbances can be particularly dangerous in neonates and infants, potentially leading to life-threatening salt-wasting crises. Rare hypoaldosteronism encompasses several distinct subtypes, including isolated aldosterone synthase deficiency (due to mutations in the CYP11B2 gene), familial hyperreninemic hypoaldosteronism, and pseudohypoaldosteronism (types 1 and 2), where aldosterone levels may be normal or elevated but the kidneys fail to respond appropriately. The clinical presentation varies depending on the underlying cause, ranging from severe neonatal salt-wasting to milder forms presenting later in life with persistent hyperkalemia. Diagnosis typically involves measurement of serum electrolytes, plasma renin activity, and aldosterone levels, along with genetic testing when a hereditary form is suspected. Treatment depends on the specific subtype and severity. For forms involving true aldosterone deficiency, mineralocorticoid replacement therapy with fludrocortisone is the mainstay of treatment, often supplemented with sodium chloride, particularly in infants. For pseudohypoaldosteronism, high-dose sodium supplementation may be required, and in some cases, treatment with potassium-lowering agents or thiazide diuretics is employed. With appropriate management, many patients can achieve good electrolyte control, though lifelong monitoring and treatment adjustments are typically necessary. Some milder forms may improve with age, particularly certain types of pseudohypoaldosteronism type 1.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare hypoaldosteronism.

View clinical trials →

No actively recruiting trials found for Rare hypoaldosteronism at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare hypoaldosteronism community →

No specialists are currently listed for Rare hypoaldosteronism.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare hypoaldosteronism.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare hypoaldosteronismForum →

No community posts yet. Be the first to share your experience with Rare hypoaldosteronism.

Start the conversation →

Latest news about Rare hypoaldosteronism

No recent news articles for Rare hypoaldosteronism.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Rare hypoaldosteronism

What is Rare hypoaldosteronism?

Rare hypoaldosteronism (Orphanet code 181419) is a group of uncommon endocrine disorders characterized by deficient production or impaired action of aldosterone, the primary mineralocorticoid hormone produced by the adrenal glands. Aldosterone plays a critical role in regulating sodium and potassium balance and maintaining blood pressure through its action on the kidneys. When aldosterone is deficient or its signaling is impaired, patients may develop hyperkalemia (elevated blood potassium levels), hyponatremia (low blood sodium levels), metabolic acidosis, dehydration, and hypotension (low bl